(Q46886435)

26 December 2017

title

Apolipoprotein D is associated with long-term outcome in patients with schizophrenia (English)

1 reference

26 December 2017

1 reference

1

1 reference

26 December 2017

Thomas Werge

11

object named as

Werge T

1 reference

26 December 2017

9

Parnas J

1 reference

26 December 2017

2

Hemmingsen RP

1 reference

26 December 2017

Wang AG

3

1 reference

26 December 2017

Olsen L

4

1 reference

26 December 2017

Timm S

5

1 reference

26 December 2017

Søeby K

6

1 reference

26 December 2017

Jakobsen KD

7

1 reference

26 December 2017

Fenger M

8

1 reference

26 December 2017

Rasmussen HB

10

1 reference

26 December 2017

publication date

1 March 2006

1 reference

26 December 2017

The Pharmacogenomics Journal

published in

1 reference

26 December 2017

volume

6

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

120-125

1 reference

26 December 2017

Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

From pharmacotherapy to pathophysiology: emerging mechanisms of apolipoprotein D in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Cholesterol-induced protein sorting: an analysis of energetic feasibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Regulation of sodium channel function by bilayer elasticity: the importance of hydrophobic coupling. Effects of Micelle-forming amphiphiles and cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Structure of human apolipoprotein D: locations of the intermolecular and intramolecular disulfide links

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Exon-intron structure and evolution of the Lipocalin gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Genetic predictors of therapeutic response to clozapine: current status of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Antipsychotic drugs differentially modulate apolipoprotein D in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Reliability of clinical ICD-10 schizophrenia diagnoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Exonic splicing enhancer motif recognized by human SC35 under splicing conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Rational inferences about departures from Hardy-Weinberg equilibrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Arachidonic acid binds to apolipoprotein D: implications for the protein's function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

Immunologic and steroid binding properties of the GCDFP-24 protein isolated from human breast gross cystic disease fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500350

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.TPJ.6500350

1 reference

26 December 2017

1 reference

26 December 2017